Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Aerosol: SOP for Conducting Internal Audits for Aerosol Manufacturing – V 2.0

Posted on By

Aerosol: SOP for Conducting Internal Audits for Aerosol Manufacturing – V 2.0

SOP for Conducting Internal Audits for Aerosol Manufacturing

Department Aerosol
SOP No. SOP/Aerosol/167/2025
Supersedes SOP/Aerosol/167/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the methodology for conducting internal audits in aerosol manufacturing facilities. Internal audits ensure compliance with Good Manufacturing Practices (GMP), identify process improvements, and mitigate risks associated with non-compliance.

2. Scope

This SOP applies to all departments involved in aerosol manufacturing, including Production, Quality Assurance (QA), Quality Control (QC), Engineering, and Regulatory Affairs. It covers audit planning, execution, reporting, and corrective action follow-ups.

3. Responsibilities

  • Internal Audit Team: Responsible for planning and executing internal audits and ensuring adherence to regulatory guidelines.
  • Quality Assurance (QA) Team: Responsible for reviewing audit reports and ensuring corrective actions are implemented.
  • Department Heads: Responsible for addressing audit findings and implementing corrective and preventive actions (CAPA).
  • Regulatory Affairs Team: Responsible for ensuring compliance with external regulatory requirements.
See also  Aerosol: SOP for Inspecting Aerosol Cans Before Packing - V 2.0

4. Accountability

The Quality Assurance (QA) Manager is accountable for ensuring internal audits are conducted as per this SOP and that necessary corrective actions are taken.

5. Procedure

5.1. Planning Internal Audits

  1. The Internal Audit Team develops an annual audit schedule covering all departments.
  2. Audits should be conducted quarterly, with additional audits scheduled in case
of non-compliance findings.
  • Audit scope, objectives, and criteria are defined in the Internal Audit Plan (Annexure-1).
  • 5.2. Conducting Internal Audits

    1. Auditors should follow a checklist covering key GMP requirements, documentation, safety protocols, and equipment maintenance.
    2. Departments should provide access to all relevant records, including batch manufacturing records (BMRs), validation reports, and training logs.
    3. Observations, deviations, and best practices are documented in the Audit Findings Report (Annexure-2).

    5.3. Identifying Non-Conformances

    1. Audit findings should be classified as:
      • Critical: Potential impact on product safety, compliance violations.
      • Major: Process deviations that could lead to non-compliance.
      • Minor: Improvement areas that do not affect product quality.
    2. All non-conformances are documented in the Non-Conformance Report (Annexure-3).

    5.4. Implementing Corrective and Preventive Actions (CAPA)

    1. Each department must submit a CAPA plan within 15 days of receiving the audit report.
    2. CAPA implementation is tracked in the CAPA Tracking Log (Annexure-4).
    3. Follow-up audits should be conducted to verify the effectiveness of corrective actions.

    5.5. Closing the Audit

    1. Once all corrective actions are completed, the Internal Audit Team closes the audit findings.
    2. The final audit status is documented in the Internal Audit Closure Report (Annexure-5).

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • QC: Quality Control
    • SOP: Standard Operating Procedure
    • BMR: Batch Manufacturing Record
    • CAPA: Corrective and Preventive Action

    7. Documents

    1. Internal Audit Plan (Annexure-1)
    2. Audit Findings Report (Annexure-2)
    3. Non-Conformance Report (Annexure-3)
    4. CAPA Tracking Log (Annexure-4)
    5. Internal Audit Closure Report (Annexure-5)

    8. References

    • Good Manufacturing Practice (GMP) Guidelines
    • ISO 9001 – Quality Management Systems
    • FDA Guidance on Internal Audits

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Internal Audit Plan

    Audit ID Department Audit Date Lead Auditor Scope
    AUD-001 Production 06/02/2025 Rajesh Patel GMP Compliance

    Annexure-2: Audit Findings Report

    Finding ID Category Description Risk Level Action Plan
    FND-001 GMP Compliance Incomplete batch records Major Training scheduled

    Annexure-3: Non-Conformance Report

    Non-Conformance ID Description Root Cause Corrective Action
    NC-001 Improper equipment calibration Missed calibration schedule Updated calibration SOP

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma
    01/01/2025 V 2.0 Updated audit procedures GMP Compliance Anjali Sharma
    See also  Aerosol: SOP for Safety Checks on Gas Filling Machines - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Analytical Method Development: Method Transfer for Dissolution Studies – V 2.0
    Next Post: BA-BE Studies: SOP for Auto-sampler Stability of Samples – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version